ClearBridge Investments - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 132 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
ClearBridge Investments ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$9,932,000
-35.0%
871,200
-8.7%
0.01%
-36.4%
Q2 2021$15,270,000
-10.8%
953,776
-0.4%
0.01%
-15.4%
Q1 2021$17,118,000
+97.3%
957,898
+49.1%
0.01%
+85.7%
Q4 2020$8,677,000
+16.4%
642,243
+1.4%
0.01%
+16.7%
Q3 2020$7,453,000
-20.6%
633,193
-0.5%
0.01%
-25.0%
Q2 2020$9,390,000
+14.3%
636,175
+4.5%
0.01%
-11.1%
Q1 2020$8,217,000
-43.7%
608,695
-0.7%
0.01%
-25.0%
Q4 2019$14,583,000
+86.3%
612,751
+50.4%
0.01%
+71.4%
Q3 2019$7,829,000407,3300.01%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 246,563$2,244,0001.36%
LEVIN CAPITAL STRATEGIES, L.P. 1,435,876$13,066,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,695,020$42,725,0000.96%
DCF Advisers, LLC 189,565$1,725,0000.76%
DAFNA Capital Management LLC 289,040$2,630,0000.68%
RICE HALL JAMES & ASSOCIATES, LLC 1,678,609$15,275,0000.61%
Rhenman & Partners Asset Management AB 589,200$5,362,0000.53%
PFM Health Sciences, LP 1,088,566$9,906,0000.37%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$2,819,0000.36%
Granahan Investment Management 1,588,944$14,459,0000.36%
View complete list of AERIE PHARMACEUTICALS INC shareholders